Skip to main content

T81.82XA vs T82

T81.82XA (Emphysema (subcutaneous) resulting from a procedure, initial encounter) compared with T82 (Complications of cardiac and vascular prosthetic devices, implants and grafts), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).

Can these codes be reported together?

Yes, when both are documented. T81.82XA carries an Excludes2 note covering T82: “complication of prosthetic devices, implants and grafts (T82-T85)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

Side by side

T81.82XAEmphysema (subcutaneous) resulting from a procedure, initial encounterT82Complications of cardiac and vascular prosthetic devices, implants and grafts
Billing statusBillableNon-billable header

Report instead: T82.01XA, T82.01XD, T82.01XS, T82.02XA, T82.02XD

ClassificationS00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)
DefinitionEmphysema (subcutaneous) resulting from a procedure, initial encounter is a billable ICD-10-CM diagnosis code (T81.82A).Complications of cardiac and vascular prosthetic devices, implants and grafts is a non-billable ICD-10-CM category code (T82).
7th characterThe appropriate 7th character is to be added to each code from category T81The appropriate 7th character is to be added to each code from category T82
Use additional code
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
code(s) to identify the specified condition resulting from the complication
code to identify devices involved and details of circumstances (Y62-Y82)
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
code(s) to identify the specified condition resulting from the complication
code to identify devices involved and details of circumstances (Y62-Y82)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources